Aclaris Therapeutics Inc Working Capital to Net Assets Ratio
Aclaris Therapeutics Inc working capital to net assets ratio. Aclaris Therapeutics Inc (ACRS) has a Working Capital to Net Assets ratio of 62.4% as of September 2025. Working capital of $74.96 Million (current assets of $100.59 Million minus current liabilities of $25.63 Million) is measured against net assets of $120.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ACRS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Aclaris Therapeutics Inc (2013–2024)
Working capital to net assets ratio of Aclaris Therapeutics Inc from 2013 to 2024. This chart shows how Aclaris Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 62.4%, reflecting working capital of $74.96 Million against net assets of $120.10 Million USD. See Aclaris Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Aclaris Therapeutics Inc Working Capital to Net Assets Ratio by Year (2013–2024)
Aclaris Therapeutics Inc working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Aclaris Therapeutics Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Aclaris Therapeutics Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.7% | $94.36 Million | $155.55 Million | $125.95 Million | $31.60 Million | ▼ -1.6 pp |
| 2023 | 62.3% | $97.90 Million | $157.18 Million | $128.86 Million | $30.95 Million | ▼ -43.8 pp |
| 2022 | 106.1% | $209.61 Million | $197.62 Million | $231.55 Million | $21.94 Million | ▲ +13.8 pp |
| 2021 | 92.3% | $182.10 Million | $197.34 Million | $205.03 Million | $22.93 Million | ▼ -20.9 pp |
| 2020 | 113.2% | $42.62 Million | $37.65 Million | $57.49 Million | $14.87 Million | ▲ +25.4 pp |
| 2019 | 87.8% | $61.37 Million | $69.91 Million | $83.80 Million | $22.43 Million | ▲ +17.1 pp |
| 2018 | 70.7% | $152.16 Million | $215.12 Million | $179.50 Million | $27.34 Million | ▼ -16.3 pp |
| 2017 | 87.1% | $196.09 Million | $225.26 Million | $208.85 Million | $12.76 Million | ▼ -12.0 pp |
| 2016 | 99.1% | $167.91 Million | $169.49 Million | $174.13 Million | $6.22 Million | ▲ +1.3 pp |
| 2015 | 97.8% | $90.48 Million | $92.52 Million | $92.04 Million | $1.55 Million | ▲ +169.5 pp |
| 2014 | -71.7% | $14.88 Million | $-20.75 Million | $16.33 Million | $1.45 Million | ▲ +70.4 pp |
| 2013 | -142.1% | $13.02 Million | $-9.16 Million | $13.39 Million | $367.00K | — |